Search clinical trials for: Patients with relapsed/refractory DLBCL.
Total 194428 results
-
Hospices Civils de LyonCompletedTo Characterize and Compare Clinical, Pathological and Molecular FeaturesFrance
-
The First Affiliated Hospital with Nanjing Medical...RecruitingEBV-Positive DLBCL, NosChina
-
Memorial Sloan Kettering Cancer CenterActinium PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-ALL | DLBCL | DLBCL, Nos Genetic Subtypes | B ALL | Dlbcl-Ci | DLBCL Unclassifiable | DLBCL Activated B-Cell Type | DLBCL Germinal Center B-Cell Type | HGBL | HGBL, NosUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingDLBCL | Untreated | MYC Gene RearrangementChina
-
Fondazione Italiana Linfomi - ETSJanssen-Cilag S.p.A.Recruiting
-
University Hospital, SaarlandCompletedDLBCL | Old Age; DebilityGermany
-
PIQUR Therapeutics AGCompletedPrimary Central Nervous System Lymphoma
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
PIQUR Therapeutics AGWithdrawnPrimary Central Nervous System LymphomaFrance
-
First Affiliated Hospital of Zhejiang UniversityUnknown
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
Ionis Pharmaceuticals, Inc.AstraZenecaCompletedLymphoma | DLBCL | Advanced CancersUnited States
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
Grupo Argentino de Tratamiento de la Leucemia AgudaRecruitingLymphoma, Non-Hodgkin's, AdultArgentina
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
The Lymphoma Academic Research OrganisationTerminated
-
Beijing InnoCare Pharma Tech Co., Ltd.Completed
-
MorphoSys AGIqvia Pty LtdRecruitingDiffuse Large B-cell LymphomaUnited States
-
University Hospital TuebingenHoffmann-La RocheCompletedPrimary Gastric Diffuse-Large B-Cell LymphomaGermany
-
The Lymphoma Academic Research OrganisationCHU de NancyCompleted
-
Shandong New Time Pharmaceutical Co., LTDNot yet recruiting
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell LymphomaItaly
-
Curis, Inc.CompletedRelapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsUnited States, Spain
-
Fujian Medical UniversityActive, not recruitingDiffuse Large B-cell LymphomaChina
-
Fondazione Italiana Linfomi - ETSActive, not recruitingLymphoma | Large B-Cell | Diffuse Large B-CellItaly
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.RecruitingDiffuse Large B-cell LymphomaChina
-
Genelabs TechnologiesUnknownLupusUnited States, Mexico
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
Guangdong Provincial People's HospitalUnknownPrimary CNS LymphomaChina
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
Fudan UniversityCompleted
-
Gruppo Italiano Terapie Innovative nei LinfomiCompletedDiffuse Large B-Cell LymphomaItaly
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownRelapsed DLBCL and PT/NKCLsChina
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
Wuhan UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieHoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma (DLBCL) | Follicular NHL Grade 3bHong Kong, Thailand, Sweden, Taiwan, Mexico, Austria, Serbia, China, Czech Republic, Australia, Malaysia, Croatia, Israel, South Africa, Bosnia and Herzegovina, Brazil, Bulgaria, Estonia, Latvia, Macedonia, The Former Yugoslav... and more
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Nervous System Lymphoma | Recurrent Primary Vitreoretinal DLBCL | Refractory Nervous System Lymphoma | Refractory Primary Vitreoretinal DLBCLUnited States
-
Polish Lymphoma Research GroupCompletedDiffuse Large B Cell LymphomaPoland
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Completed
-
Centre Henri BecquerelCompletedDiffuse Large B Cell Lymphoma | Grade IIIB Follicular LymphomaFrance
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaSpain, United States, United Kingdom, Italy, Poland, Belgium, Germany, Czechia, France, Hungary
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States